STAT+: Trump’s secretive pharma deals may undermine ‘most-favored nation’ pricing, an analysis suggests
The projected savings from a highly touted Trump administration plan to lower Medicare drug costs may be drastically reduced — by as much as 80% — thanks to secretive deals cut with more than two dozen pharmaceutical companies, according to a new…
ImpactMinor 13/100
Why it mattersRule-based estimate: soft/evergreen signals; trust 8/10.
Regions🌐 Global
Published1 d ago (Sun, 13 Sep 2026 22:30:00 GMT)
RetrievedMon, 14 Sep 2026 17:39:54 GMT via rss
ClassifiedMon, 14 Sep 2026 17:40:00 GMT by heuristic
AuthorEd Silverman